Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:SNMX

Senomyx (SNMX) Stock Price, News & Analysis

Senomyx logo

About Senomyx Stock (NASDAQ:SNMX)

Key Stats

Today's Range
$1.49
$1.49
50-Day Range
N/A
52-Week Range
$0.83
$1.71
Volume
N/A
Average Volume
151,720 shs
Market Capitalization
$72.03 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Senomyx, Inc. discovers, develops, and commercializes flavor ingredients and natural high intensity sweeteners primarily for the packaged food, beverage, and ingredient supply industries in the United States. The company develops and/or commercializes sweet, savory and salt flavor ingredients, bitter blockers and cooling agents. It sells various flavor ingredients directly to flavor companies. The company has collaboration agreements with Ajinomoto Co., Inc.; Firmenich SA; and PepsiCo, Inc. Senomyx, Inc. was founded in 1998 and is headquartered in San Diego, California.

Receive SNMX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Senomyx and its competitors with MarketBeat's FREE daily newsletter.

SNMX Stock News Headlines

Disty Technologies DYT
AKD Securities Ltd Ordinary Shares AKDSL
Financial Prophecy
The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.
NZ Automotive Investments Ltd (NZA)
Senomyx, Inc.(SNMX)
See More Headlines

SNMX Stock Analysis - Frequently Asked Questions

Senomyx, Inc. (NASDAQ:SNMX) released its quarterly earnings data on Thursday, August, 2nd. The specialty chemicals company reported ($0.08) EPS for the quarter, topping analysts' consensus estimates of ($0.09) by $0.01. The specialty chemicals company had revenue of $3.29 million for the quarter. Senomyx had a negative trailing twelve-month return on equity of 15.80% and a negative net margin of 9.11%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Senomyx investors own include Aralez Pharmaceuticals (ARLZ), Heron Therapeutics (HRTX), Novavax (NVAX), Rexahn Pharmaceuticals (REXN), Vical (VICL), (CASC) (CASC) and DURECT (DRRX).

Company Calendar

Last Earnings
8/02/2018
Today
11/21/2024

Industry, Sector and Symbol

Industry
Commercial Physical Research
Sub-Industry
N/A
Current Symbol
NASDAQ:SNMX
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
$-1,260,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$29.32 million
Book Value
$0.39 per share

Miscellaneous

Free Float
N/A
Market Cap
$72.03 million
Optionable
Optionable
Beta
1.33
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:SNMX) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners